The board of directors of Aarti Drugs on Thursday approved the issuance of fully paid-up bonus share in the ratio of 3:1 (three bonus shares of ₹10 each for one fully paid- up equity share). The company will intimate the 'record date' for determining eligible shareholders entitled to receive bonus shares in due course. The board has also approved the increase in authorised share capital of the company from ₹25 crore to ₹120 crore by creation of additional 9.5 lakh shares. Shares of Aarti Drugs closed 18 per cent higher at ₹2,838.90 on the BSE.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.